Influencer Claudia Oshry is getting back on weight loss drugs once again.
Oshry, who has been open about her usage of GPL-1s for weight loss in the past, stopped taking them during her pregnancy and while breastfeeding.
Now, she has excitedly announced her return to taking the medication in a new Instagram post.
In the video, Oshry is seen with cabbage placed in her bra, a home remedy to help dry up breast milk supply.
Then, she reached into the fridge to pull out the GLP-1 medication known as Zepbound. Oshry captioned the video simply, “WAR IS OVER.”
In the comments, Oshry’s fans congratulated her on the milestone she has long waited for in her motherhood journey.
“Honestly, excited for you,” one fan commented on the post. “YESS QUEEN GET THAT BODY,” another chimed in.
Oshry welcomed her first child, Reuben, with her husband, Ben Soffer, back in May. The couple announced the news via a joint Instagram post on May 24.
“Things I did? That. 🩵,” Oshry said in the caption, next to a picture of her holding the baby in the hospital with her husband standing beside them.
Because the widespread use of GLP-1 medications is still fairly new, the effects of utilizing them during breastfeeding are largely unknown.
“We have no data on what that would do to a newborn infant if these [drugs] are transmitted through breast milk,” Dr. Fatima Cody Stanford, an obesity medicine physician at Massachusetts General Hospital in Boston and an associate professor of medicine and pediatrics at Harvard Medical School, shared with TODAY.com. “I don’t see that as safe because these medications haven’t been tested in a population that’s that young.”
However, a small study published in 2024 tested eight participants’ breastmilk while they took the weight loss drugs and found that no semaglutide made its way into their breastmilk.
In addition to the fact that the 2024 study was very small, there are also still no definitive studies as to whether taking GLP-1 medications while breastfeeding will result in less nutritious breast milk due to the mother’s decrease in caloric intake.
In the medication guide for Zepbound, the specific GLP-1 that Oshry is taking, the manufacturer still maintains that it “may pass into your breast milk” and instructs users to “talk to your healthcare provider about the best way to feed your baby while using Zepbound.”
Information regarding health and well-being is provided for awareness, education and general information. Health benefits of various medicines, diets, weight-loss strategies and foods are the opinions of the authors and/or those they interviewed, and there may be differing views on many of the topics covered, including evolving research, opinions, benefits and efficacy. This article is meant to inform the general reader and is not a substitute for medical advice from a physician or nutritional advice from a dietitian and/or nutritionist. Please refrain from starting, stopping or consuming any medication or regimen without the supervision of a trained physician. Please beware that in this emerging field of research, medications could cause adverse effects and problems not reported here. Please consult a doctor if you have chronic ailments or feel adverse side effects after starting a drug, nutrition or weight-loss regimen, and do not ingest, inject or otherwise use items to which you have sensitivities or may be allergic. Readers should consult a licensed health care professional who knows their personal medical history on matters relating to their health and well-being, including being aware of potential interactions with medications they are taking and conflicts with other wellness-related goals. Patients seeking treatment for weight loss should consult a physician trained in management of overweight or obesity.
